CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-11 | Wood Larry L Global President TAVR & Surg | Grant or award · Performance Rights | +9,725 | 9,725 | ||
| 2023-05-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award | +6,425 | 39,502.69 | ||
| 2023-05-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award · Employee Stock Option (Right to Acquire) | +54,200 | 54,200 | ||
| 2023-05-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Grant or award · Performance Rights | +8,025 | 8,025 | ||
| 2023-05-11 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Grant or award | +1,575 | 173,664.78 | ||
| 2023-05-11 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Grant or award · Employee Stock Option (Right to Acquire) | +13,300 | 13,300 | ||
| 2023-05-11 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Grant or award · Performance Rights | +1,975 | 1,975 | ||
| 2023-05-11 | Zovighian Bernard J President | Grant or award | +22,525 | 44,552.87 | ||
| 2023-05-11 | Zovighian Bernard J President | Grant or award · Employee Stock Option (Right to Acquire) | +173,700 | 173,700 | ||
| 2023-05-11 | Zovighian Bernard J President | Grant or award · Performance Rights | +28,150 | 28,150 | ||
| 2023-05-11 | Szyman Catherine M. CVP, Critical Care | Grant or award | +6,525 | 35,055.78 | ||
| 2023-05-11 | Szyman Catherine M. CVP, Critical Care | Grant or award · Employee Stock Option (Right to Acquire) | +50,400 | 50,400 | ||
| 2023-05-11 | Szyman Catherine M. CVP, Critical Care | Grant or award · Performance Rights | +8,175 | 8,175 | ||
| 2023-05-11 | Chopra Daveen CVP, TMTT | Grant or award | +6,475 | 25,450 | ||
| 2023-05-11 | Chopra Daveen CVP, TMTT | Grant or award · Employee Stock Option (Right to Acquire) | +49,900 | 49,900 | ||
| 2023-05-11 | Chopra Daveen CVP, TMTT | Grant or award · Performance Rights | +8,100 | 8,100 | ||
| 2023-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Grant or award | +9,450 | 27,744 | ||
| 2023-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Acquire) | +72,900 | 72,900 | ||
| 2023-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Grant or award · Performance Rights | +11,825 | 11,825 | ||
| 2023-05-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +2,500 | $36.75 | $92K | 35,577.69 |
Page 39 of 43 · 841 trades